Astex Joins Structural Biology Partnership at the European Synchrotron Radiation Facility
November 11, 2002 04:18 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Nov. 11, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has joined the new Partnership for Structural Biology (PSB)...
Sectra Increases Customer Benefit Through New Partnership
November 05, 2002 03:11 ET
|
Sectra
LINKOPING, Sweden, Nov. 5, 2002 (PRIMEZONE) -- The Swedish medical technology and IT company Sectra (Other OTC:SSBBF) (Stockholm:SECTb) has signed an agreement with the Swedish medical technology...
Astex Determines Structure of the Key Drug Metabolising Enzyme -- Human Cytochrome P450 3A4
October 28, 2002 04:13 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 28, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has solved the 3-dimensional crystal structure of human cytochrome...
BioFocus and Xention Enter Cardiovascular Drug Discovery Collaboration
October 07, 2002 07:33 ET
|
Xention
CAMBRIDGE, U.K. and Sittingbourne, Kent, U.K., Oct. 7, 2002 (PRIMEZONE) -- BioFocus plc (BioFocus), the collaborative drug discovery company and Xention Discovery Ltd. (Xention), the specialist ion...
Former AstraZeneca R&D Head Appointed New Chairman of Gyros AB
October 07, 2002 03:45 ET
|
Gyros
UPPSALA SCIENCE PARK, Sweden, Oct. 7, 2002 (PRIMEZONE) -- Gyros AB today announced the appointment of Dr. Claes Wilhelmsson as chairman of the board. Dr. Wilhelmsson is the former Executive Director...
Change of CEO at Medivir
September 10, 2002 03:26 ET
|
Medivir
HUDDINGE, Sweden, Sept. 10, 2002 (PRIMEZONE) -- Jonas Frick, CEO of Medivir since Stock Exchange listing in 1996, will leave the Company for a role as a Senior Partner of Scandinavian Life Science...
Biovitrum: Swedish Biotech Companies Form New Industry Organization -- 'SwedenBIO'
September 04, 2002 04:48 ET
|
Biovitrum AB
STOCKHOLM, Sweden, Sept. 4, 2002 (PRIMEZONE) -- SwedenBIO is a new industry association that will work actively to promote the successful establishment of internationally competitive biotechnology...
Actelion to List on SWX Main Market on September 9, 2002; Trading Symbol ATLN Remains Unchanged; Full Quarterly Reporting to Continue
August 27, 2002 01:49 ET
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Aug. 27, 2002 (PRIMEZONE) -- Actelion (SWX:ATLN) announced today that company's bearer shares will list be listed on the SWX Main Market board as of Monday, September 9,...
CeNeS Announces Divestment of Its Ion Channel Technology Business
August 15, 2002 04:12 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Aug. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spinout of its ion channel technology development business (Channelwork) as part of the ongoing...
Newport Corporation Reports Second Quarter and Six-Month 2002 Results; Financial Performance in Line with Expectations
July 23, 2002 16:15 ET
|
Newport Corporation
IRVINE, Calif., July 23, 2002 (PRIMEZONE) -- Newport Corporation (Nasdaq:NEWP) today reported financial results for the second quarter and six months ended June 30, 2002, reflecting continued...